ROI

Jazz Pharma's lung cancer drug Zepzelca fails a key trial, raising regulatory questions. Yet its strength in another setting reveals a complex drug development system.

Industrial giants struggle to scale automation beyond pilot projects. A new CEO playbook from ASI, backed by millions of autonomous miles, offers a blueprint.

While firms spend billions on tech, a new book argues the biggest data breaches stem from leadership gaps and process failures. Is your boardroom the real front line?

FCPT's latest acquisition seems minor, but it reveals a powerful strategy for navigating economic uncertainty by targeting essential, service-based real estate.

With a $20M Series A led by L Catterton, Dr. Muneeb Shah's REMEDY is disrupting skincare. Here's how accessible science is winning over consumers.

Chicago's Pure Lithium named a WEF Technology Pioneer, validating its disruptive lithium metal battery and a model that could upend global supply chains.

A new AI platform is saving millions by acting as a 'digital Chief Time Officer,' tackling the chronic delays plaguing the world's biggest projects.

Beyond solar panels and ESG reports, JFK's $9.5B New Terminal One is a blueprint for climate-proof infrastructure. Here’s why it redefines the 2026 travel experience.

As NFL stadiums undergo costly transformations for FIFA 2026, the real challenge lies in the unseen details designed to protect the world’s top athletes.

Low Earth Orbit satellites promise global connectivity, but performance issues persist. A new software solution says it has the answer. Is this the key?

A novel case study reveals how targeted chemotherapy delivery is outsmarting stubborn tumors, highlighting a metabolic victory even when size remains unchanged.

One year in, Brazil's Pix Automático isn't just a new payment tool. It's a market maker, bringing millions of new consumers to the global digital economy.

Blue Jay Gold bets $14.7M on a modern strategy: using data science to reinterpret a historic Yukon mine. But can tech overcome market and regulatory hurdles?

Truist's 63% patent boom is making headlines, but the real story is a strategic fusion of AI and a teammate-driven culture, forging a new model for trust and innovation.

The U.S. housing market has shattered a historic price barrier, yet declining sales and economic anxiety reveal a market fundamentally at war with itself.

A key partnership between Baya Systems and Openchip aims to solve AI's hidden bottleneck, signaling a new era for chip design and European tech sovereignty.

With shareholder backing and a major acquisition nearly complete, IsoEnergy is building a global uranium powerhouse to meet soaring nuclear energy demand.

Amid a crisis in higher education, Abilene Christian University's top financial grade offers a masterclass in strategic resilience and sustainable operations.

A new platform promises to solve AI's biggest monetization headache, letting developers add real-time, usage-based billing in minutes, not months.

OneAscent Investments crosses $1B in faith-aligned ETFs, signaling a shift in investor priorities. But does performance match principle in this growing niche?